A proposed $3.5 billion sale involving Conshohocken-based Cencora drew antitrust scrutiny, and West Conshohocken sensor maker Strainsert drew coverage for its warranty return figures. In Plymouth Meeting, Inovio sought European authorization for its first FDA-approved drug and Harmony Biosciences announced appearances at two investor conferences. Here’s a look at corporate news coverage published November 16–22.
Conshohocken
Cencora. The Philadelphia Inquirer reported November 16 that the Federal Trade Commission and a group of states sued to block Covetrus’s proposed $3.5 billion purchase of Cencora’s MWI Animal Health business. The plaintiffs allege that combining the veterinary distributors would raise costs for clinics and prices for pet owners. Read The Philadelphia Inquirer’s coverage.
Advantexe Learning Solutions. The Conshohocken-based corporate training company drew coverage this week for Business in Motion, a series of short business simulations that employees can complete on a phone, tablet or computer or use in an instructor-led workshop. Participants see how decisions in areas such as finance, leadership and sales affect business performance. Advantexe announced the launch November 10. Read Advantexe’s original announcement.
West Conshohocken
Strainsert. The force sensor manufacturer drew coverage this week for a warranty return rate it says stayed below 0.5% over the past decade. In its November 10 release, Strainsert said it tests every sensor before shipment and backs each one with a two-year warranty. Read Strainsert’s original announcement.
Plymouth Meeting
Inovio Pharmaceuticals. Inovio announced November 18 that it had applied to the European Medicines Agency for conditional marketing authorization for Voceryq, a treatment for adults with recurrent respiratory papillomatosis. The application follows the U.S. Food and Drug Administration’s October 30 accelerated approval. The drug was Inovio’s first to receive FDA approval, as the Philadelphia Business Journal reported in a story republished by Bizwomen on November 17. Read Inovio’s PR Newswire announcement and the Philadelphia Business Journal reporting on Bizwomen.
Harmony Biosciences. The Plymouth Meeting drugmaker announced November 19 that its management team will participate in the Evercore Healthcare Conference in Miami and the Piper Sandler Healthcare Conference in New York. Its fireside chats are scheduled for November 30 and December 3, respectively, and the company plans to webcast both. Read Harmony Biosciences’ original announcement.
Tompkins Financial Advisors. The wealth management firm appointed Stephen Burns as a wealth advisor in its Plymouth Meeting office, citybiz reported November 19. Burns joins from F.L. Putnam, where he was a principal institutional portfolio manager, and brings more than 20 years of banking and financial experience. Read the citybiz report.
The review found no qualifying corporate coverage of companies based in Lafayette Hill during the period.
This article was written by AI.